It’s with a mix of excitement and trepidation that we move into the next phase of cannabis research, still hoping to unlock the plant’s incredible therapeutic potential without letting Big Pharma swoop in and reap all the profits.
The most exciting new frontier in cannabis research this year wasn’t any individual study or published report.
It was a pair of developments (one in Canada, the other in the United States) that together promise to spur the research studies of the future on a scale never seen before, with a scope of inquiry that includes exploring potential benefits, rather than myopically focusing on potential harms.
Click here to read the complete article
David Bienenstock ~ Leafly.com ~
